Literature DB >> 26308283

Immunogenicity and pharmacokinetics of short, proline-rich antimicrobial peptides.

Luzia Holfeld1,2, Nicole Herth1,2, David Singer1,2, Ralf Hoffmann1,2, Daniel Knappe1,2.   

Abstract

AIM: The potential of proline-rich antimicrobial peptides (PrAMPs) to treat multidrug-resistant Gram-negative pathogens has been intensively investigated. They are efficacious at low doses in infection models and well tolerated in healthy mice at high doses. METHODS &
RESULTS: PrAMPs Onc72 and Api88 were nonimmunogenic in mice unless conjugated to a carrier protein. Monoclonal IgG1/IgG2b antibodies produced by hybridoma cells were mapped to different Onc72 regions and combined in a sandwich-ELISA in a pharmacokinetic study. Onc72 was detected at concentrations up to 32 µg/ml in murine blood after administering 20 mg/kg and reached several organs within 10 min.
CONCLUSION: Both PrAMPs were not immunogenic and Onc72 concentrations in blood were well above the minimal inhibitory concentrations for Enterobacteriaceae further confirming their potential as novel antibiotics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26308283     DOI: 10.4155/fmc.15.91

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  6 in total

1.  A Novel Proline-Rich Cathelicidin from the Alpaca Vicugna pacos with Potency to Combat Antibiotic-Resistant Bacteria: Mechanism of Action and the Functional Role of the C-Terminal Region.

Authors:  Pavel V Panteleev; Victoria N Safronova; Roman N Kruglikov; Ilia A Bolosov; Ivan V Bogdanov; Tatiana V Ovchinnikova
Journal:  Membranes (Basel)       Date:  2022-05-12

2.  In vivo Efficacy and Pharmacokinetics of Optimized Apidaecin Analogs.

Authors:  Rico Schmidt; Daniel Knappe; Elisabeth Wende; Eszter Ostorházi; Ralf Hoffmann
Journal:  Front Chem       Date:  2017-03-20       Impact factor: 5.221

3.  Continuous Subcutaneous Delivery of Proline-Rich Antimicrobial Peptide Api137 Provides Superior Efficacy to Intravenous Administration in a Mouse Infection Model.

Authors:  Daniel Knappe; Rico Schmidt; Knut Adermann; Ralf Hoffmann
Journal:  Front Microbiol       Date:  2019-10-02       Impact factor: 5.640

Review 4.  Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms.

Authors:  Tania Vanzolini; Michela Bruschi; Andrea C Rinaldi; Mauro Magnani; Alessandra Fraternale
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

Review 5.  Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds.

Authors:  Małgorzata Bondaryk; Monika Staniszewska; Paulina Zielińska; Zofia Urbańczyk-Lipkowska
Journal:  J Fungi (Basel)       Date:  2017-08-26

6.  Quantitation of a Novel Engineered Anti-infective Host Defense Peptide, ARV-1502: Pharmacokinetic Study of Different Doses in Rats and Dogs.

Authors:  Alexandra Brakel; Daniela Volke; Carl N Kraus; Laszlo Otvos; Ralf Hoffmann
Journal:  Front Chem       Date:  2019-11-13       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.